MeasuredReferenceTepotinib targets C_MET, NTRK3. Strongest hallmark effect: tumor promoting inflammation.
Top hallmarks
- tumor promoting inflammation1.4k
- proliferation1.2k
- evading apoptosis1.2k
Top pathways disrupted
- pi3k akt mtor signaling2.8k
- apical junction2.2k
- apoptosis2.1k
Resistance landscape — Tepotinib
MeasuredReference10 known oncogenic variants exist on Tepotinib's top targets — see detail for inhibition impact.